Impact Funding Resources
The aim of the call is to support research that 1) build our understanding of molecular and cellular mechanisms governing interactions between the cardiovascular system and the other organs/systems when at least one of the two presents a pathological state, 2) build a comprehensive approach to understanding cardiovascular disease interactions, combining basic research, clinical translation, and digital innovation through international collaboration, 3) enable transnational collaboration of multidisciplinary scientists from different countries to work together across borders, taking advantage of complementary expertise and leveraging diverse patient populations and sets of data.
Start Date07 Jan 2025 End Date07 Mar 2025 Funding AmountUpto EUR 400k Funding Resource TypeGrant
Funding ProviderERA4Health
Grant
ERA4Health
2) build a comprehensive approach to understanding cardiovascular disease interactions, combining basic research, clinical translation, and digital innovation through international collaboration,
3) enable transnational collaboration of multidisciplinary scientists from different countries to work together across borders, taking advantage of complementary expertise and leveraging diverse patient populations and sets of data.
The proposals should include one of the following approaches:
• Mechanistic / experimental research,
• Identification and validation of biomarkers of organs/systems/disorders crosstalk mentioned above (including epigenetics biomarkers),
• Generation of digital models of disease(s) to study disease-disease or disease-drug.
General conditions for application
The duration of the projects will be 36 months.
Joint research proposals may be submitted by applicants belonging to one of the following categories (eligibility of project partners may vary according to national/regional regulations):
• Academia
• Clinical/public health sector
• Enterprises
• Operational stakeholders
Only transnational projects will be funded. The following conditions apply to the composition of consortia:
• A minimum of 3 and a maximum of 5 eligible partners from at least 3 different countries participating in the call. The maximum number of eligible partners can be increased up to six or seven if they include one or two partners, respectively, from an underrepresented country (Latvia, Lithuania and Slovakia).
• No more than 2 eligible partners from the same country.
• A maximum of 2 collaborators (self-funded partner not applying funding). Project partners will be funded by their relevant national/regional funding organisation. Eligible costs and funding rules vary between the respective funding organisations.
